Sesderma Sunscreen Recalled for cGMP Deviations
Sesderma is recalling 45 compacts of Screenses Color Sunscreen due to cGMP deviations. The product is distributed in Florida, Puerto Rico, Colorado, and Georgia.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source text cites cGMP deviations without reporting specific illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Sesderma, SL is recalling 45 compacts of Screenses Color Sunscreen Tinted facial make-up compact, Broad Spectrum SPF 50, Brown, 0.35 oz (10 g). The recall is due to cGMP deviations, meaning the product does not comply with current Good Manufacturing Practice requirements.
The affected product is identified by lot code H-04 and expiration date 07/2019. It was distributed to the states of Florida, Puerto Rico, Colorado, and Georgia.
Consumers should stop using the product and return it to the place of purchase for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- Screenses Color Sunscreen Tinted facial make-up compact, Broad Spectrum SPF 50, Brown, 0.35 oz (10 g), Manufactured by Sesderma S.L., Valencia, Spain, UPC 8 429979 252166
- Manufacturer
- Sesderma, SL
- Category
- Drug — Sunscreen
- Hazard
- Affected units
- 45
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot code H-04
- exp 07/2019
Distribution
Part of a larger recall action
This product is one of 10 recalled by Sesderma, SL under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Sesderma, SL
See all →- ModerateSesderma Recalls Dryses Antiperspirant Solution for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Salises Acne Gel Recalled for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Sunscreen Recalled for cGMP Non-Compliance
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 50 Sunscreen Due to cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 30 Sunscreen for cGMP Deviations
FDA (Drugs) · 2016-05-18
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14